DARA BioSciences, Inc. — Form D
DARA BioSciences, Inc. of RALEIGH, NC, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-09. The offering totals $2.0M, of which $1.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-03-09
- Form: D
- Accession: 0001316742-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $1.7M
- Remaining: $284K
- Investors: 22
- Date of first sale: 2010-02-26
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-91974-5B
Issuer
- Name: DARA BioSciences, Inc.
- CIK: 0000919745
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 8601 SIX FORKS ROAD SUITE 160, RALEIGH, NC, 27615
- Phone: 919-872-5578
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Richard A Franco | Director | Raleigh, NC |
| Gail F Liebarman | Director | Raleigh, NC |
| Richard A Franco | Executive Officer | Raleigh, NC |
| David Drutz | Director | Gaithersburg, MD |
| Haywood Cochrane | Director | Brentwood, TN |
| David D Drutz | Director | Raleigh, NC |
| David D Drutz | Executive Officer | Raleigh, NC |
| Steve F Gorlin | Director | Raleigh, NC |
| Ann A Rosar | Executive Officer | Raleigh, NC |
| Haywood D Cochrane | Director | Raleigh, NC |
| Gail F Lieberman | Director | Raleigh, NC |
| Christopher F Clement | Director | Raleigh, NC |
| Christopher F Clement | Executive Officer | Raleigh, NC |
| Gail Lieberman | Director | Raleigh, NC |
Other filings by this issuer (2)
More